Zenas BioPharma (ZBIO) Change in Acquisitions & Divestments (2025 - 2026)

Zenas BioPharma's (ZBIO) quarterly Change in Acquisitions & Divestments came in at $108.1 million in Q1 2026, up 740.98% year-on-year from $12.9 million in Q1 2025, and up 55.52% quarter-over-quarter from $69.5 million in Q4 2025.

Zenas BioPharma (ZBIO) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

Zenas BioPharma's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $108.1 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 740.98% year-over-year to $108.1 million in Q1 2026; TTM through Mar 2026 was $296.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $200.9 million, up 3248.12% from the prior year.
  • Change in Acquisitions & Divestments grew to $108.1 million in Q1 2026 per ZBIO's latest filing, from $69.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $108.1 million in Q1 2026 and bottomed at $12.9 million in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn -
2 Nanobiotix 1,924.26 Bn 1,924.20 Bn -
3 Akari Therapeutics 975.59 Bn 975.59 Bn -
4 BeOne Medicines 472.11 Bn 467.32 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.89 Bn 114.65 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn
7 Belite Bio 62.83 Bn 62.83 Bn -
8 Argenx Se 55.82 Bn 50.63 Bn 1.41 Bn
9 Revolution Medicines 37.49 Bn 37.49 Bn -
10 Zenas BioPharma 1.84 Bn 1.13 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 108.13 Mn
Mar 31, 2026 108.13 Mn
Dec 31, 2025 69.53 Mn
Dec 31, 2025 69.53 Mn
Sep 30, 2025 104.24 Mn
Sep 30, 2025 104.24 Mn
Jun 30, 2025 14.26 Mn
Jun 30, 2025 14.26 Mn
Mar 31, 2025 12.86 Mn
Mar 31, 2025 12.86 Mn